Clinical Trials Browser

Phase 1 × Lapatinib × Genitourinary × Clear all

Carcinoma, Renal Cell

NCT00516672 2017-11-13

Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors

Phase 1 Completed

30 enrolled

Genitourinary

Carcinoma, Renal Cell, Neoplasms

NCT00313599 2014-07-02

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

28 enrolled

BreastCNSGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Dysgerminoma, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Central Nervous System Neoplasms

NCT00623064 2014-07-01

Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer

Phase 1 Completed

18 enrolled

Genitourinary

Urinary Bladder Neoplasms

Clinical Trials

Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients

Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer